Study Summary
This trial is looking at the effects of a tool that uses electronic health records to help cancer survivors manage their cardiovascular health. The study will compare how well the tool works compared to usual care in terms of risk reduction and health promotion activities.
Eligible Conditions
- Prostate Cancer
- Hodgkin's Lymphoma
- Breast Cancer
- Endometrial Cancer
- Non-Hodgkin's Lymphoma
- Colorectal Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 8 Secondary · Reporting Duration: 1 year
1 year
CVH behaviors recorded in the past year
CVH factors recorded in the past year
Completed visits with primary care providers and cardiology
Number of CVH-relevant labs and treatments to manage CV risk
Number of referrals to primary care and cardiology to manage CV risk
Proportion of survivors for whom AH-HA is utilized
Baseline
Measure of tool acceptability with Tool Assessment
Proportion of patients reporting at least one non-ideal or missing CVH topic
Year 1
Patient perception and knowledge of CV risks
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Usual Care
1 of 2
Intervention - AH-HA tool
1 of 2
Active Control
Experimental Treatment
645 Total Participants · 2 Treatment Groups
Primary Treatment: AH-HA Tool in the EPIC EHR · No Placebo Group · N/A
Intervention - AH-HA tool
Other
Experimental Group · 1 Intervention: AH-HA Tool in the EPIC EHR · Intervention Types: OtherUsual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,167 Previous Clinical Trials
41,167,910 Total Patients Enrolled
539 Trials studying Prostate Cancer
503,006 Patients Enrolled for Prostate Cancer
University of Texas Southwestern Medical CenterOTHER
962 Previous Clinical Trials
1,107,842 Total Patients Enrolled
16 Trials studying Prostate Cancer
2,135 Patients Enrolled for Prostate Cancer
Washington University School of MedicineOTHER
1,826 Previous Clinical Trials
2,283,752 Total Patients Enrolled
18 Trials studying Prostate Cancer
7,533 Patients Enrolled for Prostate Cancer
Wake Forest University Health SciencesLead Sponsor
1,151 Previous Clinical Trials
1,053,088 Total Patients Enrolled
21 Trials studying Prostate Cancer
1,798 Patients Enrolled for Prostate Cancer
Kathryn Weaver, MDPrincipal InvestigatorWake Forest University Health Sciences
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:References
- Lajous, M., D. Mozaffarian, R. Mozaffarian, D. Schrag, and H.-O. Adami. 2010. “Lifestyle Prescriptions for Cancer Survivors and Their Communities”. Journal of Internal Medicine. Wiley. doi:10.1111/j.1365-2796.2010.02273.x.
- Hurt, Richard D., Jon O. Ebbert, J. Taylor Hays, and David D. McFadden. 2011. “Preventing Lung Cancer by Treating Tobacco Dependence”. Clinics in Chest Medicine. Elsevier BV. doi:10.1016/j.ccm.2011.08.004.
- Byers, T., and R. L. Sedjo. 2011. “Does Intentional Weight Loss Reduce Cancer Risk?”. Diabetes, Obesity and Metabolism. Wiley. doi:10.1111/j.1463-1326.2011.01464.x.
- Caan, Bette J., Marilyn L. Kwan, Xiao Ou Shu, John P. Pierce, Ruth E. Patterson, Sarah J. Nechuta, Elizabeth M. Poole, et al.. 2012. “Weight Change and Survival After Breast Cancer in the After Breast Cancer Pooling Project”. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR). doi:10.1158/1055-9965.epi-12-0306.
- Huffman, Mark D., Simon Capewell, Hongyan Ning, Christina M. Shay, Earl S. Ford, and Donald M. Lloyd-Jones. 2012. “Cardiovascular Health Behavior and Health Factor Changes (1988–2008) and Projections to 2020”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.111.070722.
- Weaver, Kathryn E., Randi E. Foraker, Catherine M. Alfano, Julia H. Rowland, Neeraj K. Arora, Keith M. Bellizzi, Ann S. Hamilton, Ingrid Oakley-Girvan, Gretchen Keel, and Noreen M. Aziz. 2013. “Cardiovascular Risk Factors Among Long-term Survivors of Breast, Prostate, Colorectal, and Gynecologic Cancers: A Gap in Survivorship Care?”. Journal of Cancer Survivorship. Springer Science and Business Media LLC. doi:10.1007/s11764-013-0267-9.
- Duprez, Daniel A, James Otvos, Otto A Sanchez, Rachel H Mackey, Russell Tracy, and David R Jacobs Jr.. 2016. “Comparison of the Predictive Value of Glyca and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-related Events, and Total Cancer Events”. Clinical Chemistry. Oxford University Press (OUP). doi:10.1373/clinchem.2016.255828.
- Kroenke, Candyce H., Wendy Y. Chen, Bernard Rosner, and Michelle D. Holmes. 2005. “Weight, Weight Gain, and Survival After Breast Cancer Diagnosis”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2005.01.079.
- Giordano, Sharon H., Yu-Li Lin, Yong Fang Kuo, Gabriel N. Hortobagyi, and James S. Goodwin. 2012. “Decline in the Use of Anthracyclines for Breast Cancer”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2011.40.1273.
- Sawaya, Heloisa, Igal A. Sebag, Juan Carlos Plana, James L. Januzzi, Bonnie Ky, Timothy C. Tan, Victor Cohen, et al.. 2012. “Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated with Anthracyclines, Taxanes, and Trastuzumab”. Circulation: Cardiovascular Imaging. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circimaging.112.973321.
- Meserve, Emily E., Leslie E. Lehmann, Antonio R. Perez-Atayde, and James L. LaBelle. 2014. “Cyclophosphamide-associated Cardiotoxicity in a Child After Stem Cell Transplantation for Β-thalassemia Major: Case Report and Review of the Literature”. Pediatric and Developmental Pathology. SAGE Publications. doi:10.2350/13-04-1324-cr.1.
- Davies, N J, L Batehup, and R Thomas. 2011. “The Role of Diet and Physical Activity in Breast, Colorectal, and Prostate Cancer Survivorship: A Review of the Literature”. British Journal of Cancer. Springer Science and Business Media LLC. doi:10.1038/bjc.2011.423.
- Shelburne, Nonniekaye, Bishow Adhikari, Joanna Brell, Myrtle Davis, Patrice Desvigne-Nickens, Andrew Freedman, Lori Minasian, Thomas Force, and Scot C. Remick. 2014. “Cancer Treatment–related Cardiotoxicity: Current State of Knowledge and Future Research Priorities”. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP). doi:10.1093/jnci/dju232.
- Patnaik, Jennifer L, Tim Byers, Carolyn DiGuiseppi, Dana Dabelea, and Thomas D Denberg. 2011. “Cardiovascular Disease Competes with Breast Cancer as the Leading Cause of Death for Older Females Diagnosed with Breast Cancer: A Retrospective Cohort Study”. Breast Cancer Research. Springer Science and Business Media LLC. doi:10.1186/bcr2901.
- Chowdhury, Pranesh P., Tebitha Mawokomatanda, Fang Xu, Sonya Gamble, David Flegel, Carol Pierannunzi, William Garvin, and Machell Town. 2016. “Surveillance for Certain Health Behaviors, Chronic Diseases, and Conditions, Access to Health Care, and Use of Preventive Health Services Among States and Selected Local Areas — Behavioral Risk Factor Surveillance System, United States, 2012”. MMWR. Surveillance Summaries. Centers for Disease Control MMWR Office. doi:10.15585/mmwr.ss6504a1.
- Ward, Kristy K., Nina R. Shah, Cheryl C. Saenz, Michael T. McHale, Edwin A. Alvarez, and Steven C. Plaxe. 2012. “Cardiovascular Disease Is the Leading Cause of Death Among Endometrial Cancer Patients”. Gynecologic Oncology. Elsevier BV. doi:10.1016/j.ygyno.2012.04.013.
- Rasmussen-Torvik, Laura J., Christina M. Shay, Judith G. Abramson, Christopher A. Friedrich, Jennifer A. Nettleton, Anna E. Prizment, and Aaron R. Folsom. 2013. “Ideal Cardiovascular Health Is Inversely Associated with Incident Cancer”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.112.001183.
- Kulshreshtha, Ambar, Viola Vaccarino, Suzanne E. Judd, Virginia J. Howard, William M. McClellan, Paul Muntner, Yuling Hong, Monika M. Safford, Abhinav Goyal, and Mary Cushman. 2013. “Life’s Simple 7 and Risk of Incident Stroke”. Stroke. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/strokeaha.111.000352.
- Oeffinger, Kevin C., and Emily S. Tonorezos. 2011. “The Cancer Is Over, Now What?”. Cancer. Wiley. doi:10.1002/cncr.26051.
- Jones, Lee W., Mark J. Haykowsky, Jonas J. Swartz, Pamela S. Douglas, and John R. Mackey. 2007. “Early Breast Cancer Therapy and Cardiovascular Injury”. Journal of the American College of Cardiology. Elsevier BV. doi:10.1016/j.jacc.2007.06.037.
- Byers, Tim, and Jennifer L Patnaik. 2011. “Missed Opportunities for Chronic Disease Prevention After Breast Cancer”. Women's Health. SAGE Publications. doi:10.2217/whe.11.66.
- Christian, Allison H., Denalee O’Malley, Ana Barac, Suzanne M. Miller, and Shawna V. Hudson. 2017. “Cardiovascular Risk and Communication Among Early Stage Breast Cancer Survivors”. Patient Education and Counseling. Elsevier BV. doi:10.1016/j.pec.2017.02.010.
- Gallicchio, Lisa, Carla Calhoun, David Riseberg, and Kathy Helzlsouer. 2016. “Cardiovascular Health Among Black and White Breast Cancer Patients Initiating Aromatase Inhibitor Therapy”. The Breast Journal. Hindawi Limited. doi:10.1111/tbj.12709.
- Bulten, Ben F., Annelies M. C. Mavinkurve-Groothuis, Lioe-Fee de Geus-Oei, Anton F. J. de Haan, Chris L. de Korte, Louise Bellersen, Hanneke W. M. van Laarhoven, and Livia Kapusta. 2014. “Early Myocardial Deformation Abnormalities in Breast Cancer Survivors”. Breast Cancer Research and Treatment. Springer Science and Business Media LLC. doi:10.1007/s10549-014-2997-4.
- Brana, I., and J. Tabernero. 2010. “Cardiotoxicity”. Annals of Oncology. Elsevier BV. doi:10.1093/annonc/mdq295.
- van Erning, F.N., L.N. van Steenbergen, V.E.P.P. Lemmens, H.J.T. Rutten, H. Martijn, D.J. van Spronsen, and M.L.G. Janssen-Heijnen. 2014. “Conditional Survival for Long-term Colorectal Cancer Survivors in the Netherlands: Who Do Best?”. European Journal of Cancer. Elsevier BV. doi:10.1016/j.ejca.2014.04.009.
- Foraker, Randi E., Mahmoud Abdel-Rasoul, Lewis H. Kuller, Rebecca D. Jackson, Linda Van Horn, Rebecca A. Seguin, Monika M. Safford, et al.. 2016. “Cardiovascular Health and Incident Cardiovascular Disease and Cancer”. American Journal of Preventive Medicine. Elsevier BV. doi:10.1016/j.amepre.2015.07.039.
- Folsom, Aaron R., Hiroshi Yatsuya, Jennifer A. Nettleton, Pamela L. Lutsey, Mary Cushman, and Wayne D. Rosamond. 2011. “Community Prevalence of Ideal Cardiovascular Health, by the American Heart Association Definition, and Relationship with Cardiovascular Disease Incidence”. Journal of the American College of Cardiology. Elsevier BV. doi:10.1016/j.jacc.2010.11.041.
- Thomson, Cynthia A., Cheryl L. Rock, Patricia A. Thompson, Bette J. Caan, Ellen Cussler, Shirley W. Flatt, and John P. Pierce. 2010. “Vegetable Intake Is Associated with Reduced Breast Cancer Recurrence in Tamoxifen Users: A Secondary Analysis from the Women’s Healthy Eating and Living Study”. Breast Cancer Research and Treatment. Springer Science and Business Media LLC. doi:10.1007/s10549-010-1014-9.
- Shay, Christina M., Hongyan Ning, Norrina B. Allen, Mercedes R. Carnethon, Stephanie E. Chiuve, Kurt J. Greenlund, Martha L. Daviglus, and Donald M. Lloyd-Jones. 2012. “Status of Cardiovascular Health in US Adults”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.111.035733.
- Cardinale, Daniela, Giulia Bacchiani, Marta Beggiato, Alessandro Colombo, and Carlo M. Cipolla. 2013. “Strategies to Prevent and Treat Cardiovascular Risk in Cancer Patients”. Seminars in Oncology. Elsevier BV. doi:10.1053/j.seminoncol.2013.01.008.
- Dennis Parker, Elizabeth A., Vanessa B. Sheppard, and Lucile Adams-Campbell. 2013. “Compliance with National Nutrition Recommendations Among Breast Cancer Survivors in “stepping Stone””. Integrative Cancer Therapies. SAGE Publications. doi:10.1177/1534735413503550.
- Pawloski, Pamala A., Ann M. Geiger, Reina Haque, Aruna Kamineni, Hassan Fouayzi, Jessica Ogarek, Hans V. Petersen, et al.. 2013. “Fracture Risk in Older, Long‐term Survivors of Early‐stage Breast Cancer”. Journal of the American Geriatrics Society. Wiley. doi:10.1111/jgs.12269.
- Volkova, Maria, and Raymond Russell. 2012. “Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment”. Current Cardiology Reviews. Bentham Science Publishers Ltd.. doi:10.2174/157340311799960645.
- Francis, Nataya. 2014. “The Need for Routine Monitoring of Cardiac Function in Patients Receiving 5-fluorouracil Infusion”. Clinical Journal of Oncology Nursing. Oncology Nursing Society (ONS). doi:10.1188/14.cjon.360-362.
- Khakoo, Aarif Y, and Edward TH Yeh. 2008. “Therapy Insight: Management of Cardiovascular Disease in Patients with Cancer and Cardiac Complications of Cancer Therapy”. Nature Clinical Practice Oncology. Springer Science and Business Media LLC. doi:10.1038/ncponc1225.
- Haykowsky, Mark J., John R. Mackey, Richard B. Thompson, Lee W. Jones, and D. Ian Paterson. 2009. “Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training”. Clinical Cancer Research. American Association for Cancer Research (AACR). doi:10.1158/1078-0432.ccr-09-0628.
- Saladores, P, T Mürdter, D Eccles, B Chowbay, N K Zgheib, S Winter, B Ganchev, et al.. 2014. “Tamoxifen Metabolism Predicts Drug Concentrations and Outcome in Premenopausal Patients with Early Breast Cancer”. The Pharmacogenomics Journal. Springer Science and Business Media LLC. doi:10.1038/tpj.2014.34.
- Bird, Brian R.J. Healey, and Sandra M. Swain. 2008. “Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems”. Clinical Cancer Research. American Association for Cancer Research (AACR). doi:10.1158/1078-0432.ccr-07-1033.
- Levine, Glenn N., Anthony V. D'Amico, Peter Berger, Peter E. Clark, Robert H. Eckel, Nancy L. Keating, Richard V. Milani, Arthur I. Sagalowsky, Matthew R. Smith, and Neil Zakai. 2010. “Androgen-deprivation Therapy in Prostate Cancer and Cardiovascular Risk”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.109.192695.
- Darby, Sarah C, Paul McGale, Carolyn W Taylor, and Richard Peto. 2005. “Long-term Mortality from Heart Disease and Lung Cancer After Radiotherapy for Early Breast Cancer: Prospective Cohort Study of About 300 000 Women in US SEER Cancer Registries”. The Lancet Oncology. Elsevier BV. doi:10.1016/s1470-2045(05)70251-5.
- Heidenreich, Paul A., Ingela Schnittger, H. William Strauss, Randall H. Vagelos, Byron K. Lee, Carol S. Mariscal, David J. Tate, Sandra J. Horning, Richard T. Hoppe, and Steven L. Hancock. 2007. “Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2006.07.0805.
- Vasu, Sujethra, and W Gregory Hundley. 2013. “Understanding Cardiovascular Injury After Treatment for Cancer: An Overview of Current Uses and Future Directions of Cardiovascular Magnetic Resonance”. Journal of Cardiovascular Magnetic Resonance. Springer Science and Business Media LLC. doi:10.1186/1532-429x-15-66.
- Rock, Cheryl L., and Wendy Demark-Wahnefried. 2002. “Can Lifestyle Modification Increase Survival in Women Diagnosed with Breast Cancer?”. The Journal of Nutrition. Oxford University Press (OUP). doi:10.1093/jn/132.11.3504s.
- Singla, Abhishek, Gautam Kumar, and Aditya Bardia. 2012. “Personalizing Cardiovascular Disease Prevention Among Breast Cancer Survivors”. Current Opinion in Cardiology. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/hco.0b013e3283570040.
- Lenihan, Daniel J., and Daniela M. Cardinale. 2012. “Late Cardiac Effects of Cancer Treatment”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2012.45.2938.
- Ammon, Michael, Nisha Arenja, Gregor Leibundgut, Ronny R. Buechel, Gabriela M. Kuster, Beat A. Kaufmann, and Otmar Pfister. 2013. “Cardiovascular Management of Cancer Patients with Chemotherapy-associated Left Ventricular Systolic Dysfunction in Real-world Clinical Practice”. Journal of Cardiac Failure. Elsevier BV. doi:10.1016/j.cardfail.2013.07.007.
- Snyder, Claire F., Kevin D. Frick, Kimberly S. Peairs, Melinda E. Kantsiper, Robert J. Herbert, Amanda L. Blackford, Antonio C. Wolff, and Craig C. Earle. 2009. “Comparing Care for Breast Cancer Survivors to Non-cancer Controls: A Five-year Longitudinal Study”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1007/s11606-009-0903-2.
- Snyder, Claire F., Craig C. Earle, Robert J. Herbert, Bridget A. Neville, Amanda L. Blackford, and Kevin D. Frick. 2008. “Trends in Follow-up and Preventive Care for Colorectal Cancer Survivors”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1007/s11606-007-0497-5.
- Earle, Craig C., Harold J. Burstein, Eric P. Winer, and Jane C. Weeks. 2003. “Quality of Non–breast Cancer Health Maintenance Among Elderly Breast Cancer Survivors”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2003.03.060.
- Snyder, Claire F., Kevin D. Frick, Melinda E. Kantsiper, Kimberly S. Peairs, Robert J. Herbert, Amanda L. Blackford, Antonio C. Wolff, and Craig C. Earle. 2009. “Prevention, Screening, and Surveillance Care for Breast Cancer Survivors Compared with Controls: Changes from 1998 to 2002”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2008.18.0950.
- Weaver, Kathryn E., Noreen M. Aziz, Neeraj K. Arora, Laura P. Forsythe, Ann S. Hamilton, Ingrid Oakley-Girvan, Gretchen Keel, Keith M. Bellizzi, and Julia H. Rowland. 2014. “Follow-up Care Experiences and Perceived Quality of Care Among Long-term Survivors of Breast, Prostate, Colorectal, and Gynecologic Cancers”. Journal of Oncology Practice. American Society of Clinical Oncology (ASCO). doi:10.1200/jop.2013.001175.
- Emery, Jon D., Katie Shaw, Briony Williams, Danielle Mazza, Julia Fallon-Ferguson, Megan Varlow, and Lyndal J. Trevena. 2013. “The Role of Primary Care in Early Detection and Follow-up of Cancer”. Nature Reviews Clinical Oncology. Springer Science and Business Media LLC. doi:10.1038/nrclinonc.2013.212.
- de Moor, Janet S., Angela B. Mariotto, Carla Parry, Catherine M. Alfano, Lynne Padgett, Erin E. Kent, Laura Forsythe, Steve Scoppa, Mark Hachey, and Julia H. Rowland. 2013. “Cancer Survivors in the United States: Prevalence Across the Survivorship Trajectory and Implications for Care”. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR). doi:10.1158/1055-9965.epi-12-1356.
- Fitzgerald, Karen R.. 2012. “Review of Article: The Prevention of Cardiovascular Disease in Cancer Survivors by Iyad N. Daher, MD, Tina R. Daigle, RN, MSN, Nirmanmoh Bhatia, MD, Jean-bernard Durand, MD (tex Heart Inst J 2012;39[2]:190-8)”. Journal of Vascular Nursing. Elsevier BV. doi:10.1016/j.jvn.2012.06.004.
- Yang, Quanhe, Mary E. Cogswell, W. Dana Flanders, Yuling Hong, Zefeng Zhang, Fleetwood Loustalot, Cathleen Gillespie, Robert Merritt, and Frank B. Hu. 2012. “Trends in Cardiovascular Health Metrics and Associations with All-cause and CVD Mortality Among US Adults”. Jama. American Medical Association (AMA). doi:10.1001/jama.2012.339.
- Artero, Enrique G., Vanesa España-Romero, Duck-chul Lee, Xuemei Sui, Timothy S. Church, Carl J. Lavie, and Steven N. Blair. 2012. “Ideal Cardiovascular Health and Mortality: Aerobics Center Longitudinal Study”. Mayo Clinic Proceedings. Elsevier BV. doi:10.1016/j.mayocp.2012.07.015.
- Xanthakis, Vanessa, Danielle M. Enserro, Joanne M. Murabito, Joseph F. Polak, Kai C Wollert, James L. Januzzi, Thomas J. Wang, Geoffrey Tofler, and Ramachandran S. Vasan. 2014. “Ideal Cardiovascular Health”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.114.009273.
- Cespedes Feliciano, Elizabeth M., Marilyn L. Kwan, Lawrence H. Kushi, Erin K. Weltzien, Adrienne L. Castillo, and Bette J. Caan. 2017. “Adiposity, Post-diagnosis Weight Change, and Risk of Cardiovascular Events Among Early-stage Breast Cancer Survivors”. Breast Cancer Research and Treatment. Springer Science and Business Media LLC. doi:10.1007/s10549-017-4133-8.
- Azrad, Maria, and Wendy Demark-Wahnefried. 2013. “The Association Between Adiposity and Breast Cancer Recurrence and Survival: A Review of the Recent Literature”. Current Nutrition Reports. Springer Science and Business Media LLC. doi:10.1007/s13668-013-0068-9.
- Jain, Rishi, Howard D. Strickler, Eugene Fine, and Joseph A. Sparano. 2013. “Clinical Studies Examining the Impact of Obesity on Breast Cancer Risk and Prognosis”. Journal of Mammary Gland Biology and Neoplasia. Springer Science and Business Media LLC. doi:10.1007/s10911-013-9307-3.
- Van Blarigan, Erin L., and Jeffrey A. Meyerhardt. 2015. “Role of Physical Activity and Diet After Colorectal Cancer Diagnosis”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2014.59.7799.
- Fuchs, Michael A., Kaori Sato, Donna Niedzwiecki, Xing Ye, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, et al.. 2014. “Sugar-sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (alliance)”. Edited by Antonio Moschetta. Plos ONE. Public Library of Science (PLoS). doi:10.1371/journal.pone.0099816.
- Ligibel, Jennifer. 2012. “Lifestyle Factors in Cancer Survivorship”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2012.42.0638.
- Haggstrom, David A., Neeraj K. Arora, Paul Helft, Marla L. Clayman, and Ingrid Oakley-Girvan. 2009. “Follow-up Care Delivery Among Colorectal Cancer Survivors Most Often Seen by Primary and Subspecialty Care Physicians”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1007/s11606-009-1017-6.
- Sharifi, Mona, William G. Adams, Jonathan P. Winickoff, Jing Guo, Margaret Reid, and Renée Boynton-Jarrett. 2014. “Enhancing the Electronic Health Record to Increase Counseling and Quit-line Referral for Parents Who Smoke”. Academic Pediatrics. Elsevier BV. doi:10.1016/j.acap.2014.03.017.
- Chrimes, Dillon, Nicole R. Kitos, Andre Kushniruk, and Devin M. Mann. 2014. “Usability Testing of Avoiding Diabetes Thru Action Plan Targeting (ADAPT) Decision Support for Integrating Care-based Counseling of Pre-diabetes in an Electronic Health Record”. International Journal of Medical Informatics. Elsevier BV. doi:10.1016/j.ijmedinf.2014.05.002.
- Zamora, A., F. Fernández de Bobadilla, C. Carrion, G. Vázquez, G. Paluzie, R. Elosua, M. Vilaseca, et al.. 2013. “Pilot Study to Validate a Computer-based Clinical Decision Support System for Dyslipidemia Treatment (HTE-DLP)”. Atherosclerosis. Elsevier BV. doi:10.1016/j.atherosclerosis.2013.09.029.
- Foraker, Randi E., Abigail B. Shoben, Marjorie M. Kelley, Albert M. Lai, Marcelo A. Lopetegui, Rebecca D. Jackson, Michael A. Langan, and Philip R.O. Payne. 2016. “Electronic Health Record-based Assessment of Cardiovascular Health: The Stroke Prevention in Healthcare Delivery Environments (SPHERE) Study”. Preventive Medicine Reports. Elsevier BV. doi:10.1016/j.pmedr.2016.07.006.
- Litvin, Cara B., Steven M. Ornstein, Andrea M. Wessell, Lynne S. Nemeth, and Paul J. Nietert. 2012. “Use of an Electronic Health Record Clinical Decision Support Tool to Improve Antibiotic Prescribing for Acute Respiratory Infections: The ABX-TRIP Study”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1007/s11606-012-2267-2.
- Razavi, Seyed Amirhossein, Alexis B. Carter, John D. Puskas, Sara R. Gregg, Iman F. Aziz, and Timothy G. Buchman. 2014. “Reduced Red Blood Cell Transfusion in Cardiothoracic Surgery After Implementation of a Novel Clinical Decision Support Tool”. Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health). doi:10.1016/j.jamcollsurg.2014.06.012.
- Robbins, Gregory K., William Lester, Kristin L. Johnson, Yuchiao Chang, Gregory Estey, Dominic Surrao, Kimon Zachary, et al.. 2012. “Efficacy of a Clinical Decision-support System in an HIV Practice”. Annals of Internal Medicine. American College of Physicians. doi:10.7326/0003-4819-157-11-201212040-00003.
- Kannel, William B, Ralph B D'Agostino, Lisa Sullivan, and Peter W.F Wilson. 2004. “Concept and Usefulness of Cardiovascular Risk Profiles”. American Heart Journal. Elsevier BV. doi:10.1016/j.ahj.2003.10.022.
- Rothman, Brian, Joan C. Leonard, and Michael M. Vigoda. 2012. “Future of Electronic Health Records: Implications for Decision Support”. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine. Wiley. doi:10.1002/msj.21351.
- Clauser, Steven B., Edward H. Wagner, Erin J. Aiello Bowles, Leah Tuzzio, and Sarah M. Greene. 2011. “Improving Modern Cancer Care Through Information Technology”. American Journal of Preventive Medicine. Elsevier BV. doi:10.1016/j.amepre.2011.01.014.
- Foraker, Randi E., Bobbie Kite, Marjorie Kelley, Albert M. Lai, Caryn Roth, Marcelo A. Lopetegui, Abigail B. Shoben, Michael Langan, Nicole Rutledge, and Philip R.O. Payne. 2015. “Ehr-based Visualization Tool: Adoption Rates, Satisfaction, and Patient Outcomes”. Egems (generating Evidence & Methods to Improve Patient Outcomes). Ubiquity Press, Ltd.. doi:10.13063/2327-9214.1159.
- Foraker, Randi E., Abigail B. Shoben, Marcelo A. Lopetegui, Albert M. Lai, Philip R.O. Payne, Marjorie Kelley, Caryn Roth, Hilary Tindle, Andrew Schreiner, and Rebecca D. Jackson. 2014. “Assessment of Life's Simple 7™ in the Primary Care Setting: The Stroke Prevention in Healthcare Delivery Environments (SPHERE) Study”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2014.03.007.
- Mamlin, Burke W., and William M. Tierney. 2016. “The Promise of Information and Communication Technology in Healthcare: Extracting Value from the Chaos”. The American Journal of the Medical Sciences. Elsevier BV. doi:10.1016/j.amjms.2015.10.015.
- Glasgow, Russell E., H.Garth McKay, John D. Piette, and Kim D. Reynolds. 2001. “The RE-AIM Framework for Evaluating Interventions: What Can It Tell Us About Approaches to Chronic Illness Management?”. Patient Education and Counseling. Elsevier BV. doi:10.1016/s0738-3991(00)00186-5.
- Alzaman, Naweed, Siddharth A. Wartak, Jennifer Friderici, and Michael B. Rothberg. 2013. “Effect of Patients’ Awareness of CVD Risk Factors on Health-related Behaviors”. Southern Medical Journal. Southern Medical Association. doi:10.1097/smj.0000000000000013.
- McDonald, M., R. P. Hertz, A. N. Unger, and M. B. Lustik. 2009. “Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older”. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. Oxford University Press (OUP). doi:10.1093/gerona/gln016.
- Miles, Anne, Alice Simon, and Jane Wardle. 2010. “Answering Patient Questions About the Role Lifestyle Factors Play in Cancer Onset and Recurrence”. Journal of Health Psychology. SAGE Publications. doi:10.1177/1359105309351245.
- Jones, Lee W., Kerry S. Courneya, Adrian S. Fairey, and John R. Mackey. 2004. “Effects of an Oncologist’s Recommendation to Exercise on Self-reported Exercise Behavior in Newly Diagnosed Breast Cancer Survivors: A Single-blind, Randomized Controlled Trial”. Annals of Behavioral Medicine. Oxford University Press (OUP). doi:10.1207/s15324796abm2802_5.
- Vallance, Jeffrey K.H., Kerry S. Courneya, Ronald C. Plotnikoff, Yutaka Yasui, and John R. Mackey. 2007. “Randomized Controlled Trial of the Effects of Print Materials and Step Pedometers on Physical Activity and Quality of Life in Breast Cancer Survivors”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2006.07.9988.
- Reeves, M. M., C. O. Terranova, E. G. Eakin, and W. Demark-Wahnefried. 2014. “Weight Loss Intervention Trials in Women with Breast Cancer: A Systematic Review”. Obesity Reviews. Wiley. doi:10.1111/obr.12190.
- Winters-Stone, Kerri M., and Tomasz M. Beer. 2014. “Review of Exercise Studies in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy Calls for an Aggressive Research Agenda to Generate High-quality Evidence and Guidance for Exercise as Standard of Care”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2014.55.8189.
- Hawkes, Anna L., Suzanne K. Chambers, Kenneth I. Pakenham, Tania A. Patrao, Peter D. Baade, Brigid M. Lynch, Joanne F. Aitken, Xingqiong Meng, and Kerry S. Courneya. 2013. “Effects of a Telephone-delivered Multiple Health Behavior Change Intervention (canchange) on Health and Behavioral Outcomes in Survivors of Colorectal Cancer: A Randomized Controlled Trial”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2012.45.5873.
- Zbikowski, Susan M., Brooke Magnusson, Jessica R. Pockey, Hilary A. Tindle, and Kathryn E. Weaver. 2012. “A Review of Smoking Cessation Interventions for Smokers Aged 50 and Older”. Maturitas. Elsevier BV. doi:10.1016/j.maturitas.2011.11.019.
- Stead, Lindsay F, Gillian Bergson, and Tim Lancaster. 2008. “Physician Advice for Smoking Cessation”. Edited by Lindsay F Stead. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. doi:10.1002/14651858.cd000165.pub3.
- Chang, Virginia W., and Diane S. Lauderdale. 2009. “Fundamental Cause Theory, Technological Innovation, and Health Disparities: The Case of Cholesterol in the Era of Statins”. Journal of Health and Social Behavior. SAGE Publications. doi:10.1177/002214650905000301.
- Highland, Krista Beth, Alejandra Hurtado-de-Mendoza, Cassandra A. Stanton, Chiranjeev Dash, and Vanessa B. Sheppard. 2014. “Risk-reduction Opportunities in Breast Cancer Survivors: Capitalizing on Teachable Moments”. Supportive Care in Cancer. Springer Science and Business Media LLC. doi:10.1007/s00520-014-2441-7.
- Bluethmann, Shirley M., Angela B. Mariotto, and Julia H. Rowland. 2016. “Anticipating the “silver Tsunami”: Prevalence Trajectories and Co-morbidity Burden Among Older Cancer Survivors in the United States”. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR). doi:10.1158/1055-9965.epi-16-0133.
- Kessler, Rodger S., E. Peyton Purcell, Russell E. Glasgow, Lisa M. Klesges, Rachel M. Benkeser, and C. J. Peek. 2012. “What Does It Mean to “employ” the RE-AIM Model?”. Evaluation & the Health Professions. SAGE Publications. doi:10.1177/0163278712446066.
- Glasgow, R E, T M Vogt, and S M Boles. 1999. “Evaluating the Public Health Impact of Health Promotion Interventions: The RE-AIM Framework.”. American Journal of Public Health. American Public Health Association. doi:10.2105/ajph.89.9.1322.
- Arora, Neeraj K., Bryce B. Reeve, Ron D. Hays, Steven B. Clauser, and Ingrid Oakley-Girvan. 2011. “Assessment of Quality of Cancer-related Follow-up Care from the Cancer Survivor's Perspective”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2010.32.1554.
- Lloyd-Jones, Donald M., Yuling Hong, Darwin Labarthe, Dariush Mozaffarian, Lawrence J. Appel, Linda Van Horn, Kurt Greenlund, et al.. 2010. “Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.109.192703.
- Reed, Sean M., Jaron Arbet, and Linda Staubli. 2021. “Clinical Nurse Specialists in the United States Registered with a National Provider Identifier”. Clinical Nurse Specialist. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/nur.0000000000000592.
- Murray, D. M., S. L. Pals, J. L. Blitstein, C. M. Alfano, and J. Lehman. 2008. “Design and Analysis of Group-randomized Trials in Cancer: A Review of Current Practices”. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP). doi:10.1093/jnci/djn066.
- Murray, David M., Sherri P. Varnell, and Jonathan L. Blitstein. 2004. “Design and Analysis of Group-randomized Trials: A Review of Recent Methodological Developments”. American Journal of Public Health. American Public Health Association. doi:10.2105/ajph.94.3.423.
- Eldridge, Sandra M, Deborah Ashby, Gene S Feder, Alicja R Rudnicka, and Obioha C Ukoumunne. 2004. “Lessons for Cluster Randomized Trials in the Twenty-first Century: A Systematic Review of Trials in Primary Care”. Clinical Trials. SAGE Publications. doi:10.1191/1740774504cn006rr.
- Smith, Jordan J., Philip J. Morgan, Ronald C. Plotnikoff, Kerry A. Dally, Jo Salmon, Anthony D. Okely, Tara L. Finn, Mark J. Babic, Geoff Skinner, and David R. Lubans. 2014. “Rationale and Study Protocol for the ‘active Teen Leaders Avoiding Screen-time’ (ATLAS) Group Randomized Controlled Trial: An Obesity Prevention Intervention for Adolescent Boys from Schools in Low-income Communities”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2013.11.008.
- Sandelowski, Margarete, and Jennifer Leeman. 2012. “Writing Usable Qualitative Health Research Findings”. Qualitative Health Research. SAGE Publications. doi:10.1177/1049732312450368.
- Hermans, Greet, Helena Van Mechelen, Beatrix Clerckx, Tine Vanhullebusch, Dieter Mesotten, Alexander Wilmer, Michael P. Casaer, et al.. 2014. “Acute Outcomes and 1-year Mortality of Intensive Care Unit–acquired Weakness. A Cohort Study and Propensity-matched Analysis”. American Journal of Respiratory and Critical Care Medicine. American Thoracic Society. doi:10.1164/rccm.201312-2257oc.
- Mosca, L.. 2000. “Awareness, Perception, and Knowledge of Heart Disease Risk and Prevention Among Women in the United States”. Archives of Family Medicine. CLOCKSS Archive. doi:10.1001/archfami.9.6.506.
- From Cancer Patient to Cancer Survivor: Lost in Transition: The National Academies Press; 2005.
- HIMSS. United States EMR Adoption Model. EMR Adoption Model. 2012.
- Vallance, Jeffrey K.H., Kerry S. Courneya, Ronald C. Plotnikoff, Yutaka Yasui, and John R. Mackey. 2007. “Randomized Controlled Trial of the Effects of Print Materials and Step Pedometers on Physical Activity and Quality of Life in Breast Cancer Survivors”. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). doi:10.1200/jco.2006.07.9988.
- Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, Kosary C, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis D, Chen H, Feuer E and Cronin K. SEER Cancer Statistics Review, 1975-2011. SEER. 2014.
- Foraker R, Kelley M, Wilkister T, Lin E-J and Weaver K. Oncologists' perceptions of the usability of SPHERE: an electronic health record applicaton based on Life's Simple 7. American Heart Association. 2016;133:AP075.
- Hassoon A, Appel L, Maruthur N and Yeh H-C. Abstract 15582: Cardiovascular Risk Factors in Breast Cancer Survivors: Analysis of NHANES 1999-2012. Circulation. 2015;132:A15582-A15582.
- Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis: The National Academies Press; 2013.
- Pearlstein K. Prevalence of cardiovascular disease (CVD) risk factors and preventive care among U.S. cancer survivors. Paper presented at: American Society of Clinical Oncology Annual Meeting; 2013; Chicago, IL.
- Improving Cancer-Related Outcomes with Connected Health: A Report to the President of the United States from the President's Cancer Panel. 2016.
- RE-AIM. Reach Effectiveness Adoption Implementation Maintenance. 2017;2017.
- IOM. Cancer Survivorship Care Planning. 2005.
- Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population, Board on Health Care Services, and Institute of Medicine. 2013. Delivering High-quality Cancer Care. Edited by Laura Levit, Erin Balogh, Sharyl Nass, and Patricia A. Ganz. []. National Academies Press. doi:10.17226/18359.
- Vallance JK, Courneya KS, Plotnikoff RC, Yasui Y, Mackey JR. Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J Clin Oncol. 2007 Jun 10;25(17):2352-9. doi: 10.1200/JCO.2006.07.9988.
- Rock CL, Demark-Wahnefried W. Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr. 2002 Nov;132(11 Suppl):3504S-3507S. doi: 10.1093/jn/132.11.3504S.
- Artero EG, Espana-Romero V, Lee DC, Sui X, Church TS, Lavie CJ, Blair SN. Ideal cardiovascular health and mortality: Aerobics Center Longitudinal Study. Mayo Clin Proc. 2012 Oct;87(10):944-52. doi: 10.1016/j.mayocp.2012.07.015.
- Cardinale D, Bacchiani G, Beggiato M, Colombo A, Cipolla CM. Strategies to prevent and treat cardiovascular risk in cancer patients. Semin Oncol. 2013 Apr;40(2):186-98. doi: 10.1053/j.seminoncol.2013.01.008.
- Saladores P, Murdter T, Eccles D, Chowbay B, Zgheib NK, Winter S, Ganchev B, Eccles B, Gerty S, Tfayli A, Lim JS, Yap YS, Ng RC, Wong NS, Dent R, Habbal MZ, Schaeffeler E, Eichelbaum M, Schroth W, Schwab M, Brauch H. Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer. Pharmacogenomics J. 2015 Feb;15(1):84-94. doi: 10.1038/tpj.2014.34. Epub 2014 Aug 5.
- Meserve EE, Lehmann LE, Perez-Atayde AR, Labelle JL. Cyclophosphamide-associated cardiotoxicity in a child after stem cell transplantation for beta-thalassemia major: case report and review of the literature. Pediatr Dev Pathol. 2014 Jan-Feb;17(1):50-4. doi: 10.2350/13-04-1324-CR.1. Epub 2013 Oct 21.
- Vasu S, Hundley WG. Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013 Jul 31;15(1):66. doi: 10.1186/1532-429X-15-66.
- Jain R, Strickler HD, Fine E, Sparano JA. Clinical studies examining the impact of obesity on breast cancer risk and prognosis. J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):257-66. doi: 10.1007/s10911-013-9307-3. Epub 2013 Nov 13.
- Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603. doi: 10.1161/CIRCIMAGING.112.973321. Epub 2012 Jun 28.
- Khakoo AY, Yeh ET. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nat Clin Pract Oncol. 2008 Nov;5(11):655-67. doi: 10.1038/ncponc1225. Epub 2008 Sep 16.
- Haggstrom DA, Arora NK, Helft P, Clayman ML, Oakley-Girvan I. Follow-up care delivery among colorectal cancer survivors most often seen by primary and subspecialty care physicians. J Gen Intern Med. 2009 Nov;24 Suppl 2(Suppl 2):S472-9. doi: 10.1007/s11606-009-1017-6.
- Rothman B, Leonard JC, Vigoda MM. Future of electronic health records: implications for decision support. Mt Sinai J Med. 2012 Nov-Dec;79(6):757-68. doi: 10.1002/msj.21351.
- Zbikowski SM, Magnusson B, Pockey JR, Tindle HA, Weaver KE. A review of smoking cessation interventions for smokers aged 50 and older. Maturitas. 2012 Feb;71(2):131-41. doi: 10.1016/j.maturitas.2011.11.019. Epub 2011 Dec 29.
- Caan BJ, Kwan ML, Shu XO, Pierce JP, Patterson RE, Nechuta SJ, Poole EM, Kroenke CH, Weltzien EK, Flatt SW, Quesenberry CP Jr, Holmes MD, Chen WY. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1260-71. doi: 10.1158/1055-9965.EPI-12-0306. Epub 2012 Jun 13. Erratum In: Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):319.
- Bird BR, Swain SM. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems. Clin Cancer Res. 2008 Jan 1;14(1):14-24. doi: 10.1158/1078-0432.CCR-07-1033.
- Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, Tate DJ, Horning SJ, Hoppe RT, Hancock SL. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol. 2007 Jan 1;25(1):43-9. doi: 10.1200/JCO.2006.07.0805. Erratum In: J Clin Oncol. 2007 Apr 20;25(12):1635.
- Volkova M, Russell R 3rd. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev. 2011 Nov;7(4):214-20. doi: 10.2174/157340311799960645.
- Zamora A, Fernandez de Bobadilla F, Carrion C, Vazquez G, Paluzie G, Elosua R, Vilaseca M, Martin-Urda A, Rivera A, Plana N, Masana L; VALIDA Study Group; Network of Lipid Units of Catalonia (XULA). Pilot study to validate a computer-based clinical decision support system for dyslipidemia treatment (HTE-DLP). Atherosclerosis. 2013 Dec;231(2):401-4. doi: 10.1016/j.atherosclerosis.2013.09.029. Epub 2013 Oct 18.
- Shelburne N, Adhikari B, Brell J, Davis M, Desvigne-Nickens P, Freedman A, Minasian L, Force T, Remick SC. Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities. J Natl Cancer Inst. 2014 Sep 10;106(9):dju232. doi: 10.1093/jnci/dju232. Print 2014 Sep.
- Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005 Aug;6(8):557-65. doi: 10.1016/S1470-2045(05)70251-5.
- Eldridge SM, Ashby D, Feder GS, Rudnicka AR, Ukoumunne OC. Lessons for cluster randomized trials in the twenty-first century: a systematic review of trials in primary care. Clin Trials. 2004 Feb;1(1):80-90. doi: 10.1191/1740774504cn006rr.
- Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011 Nov 8;105 Suppl 1(Suppl 1):S52-73. doi: 10.1038/bjc.2011.423.
- Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005 Mar 1;23(7):1370-8. doi: 10.1200/JCO.2005.01.079. Epub 2005 Jan 31.
- Brana I, Tabernero J. Cardiotoxicity. Ann Oncol. 2010 Oct;21 Suppl 7:vii173-9. doi: 10.1093/annonc/mdq295.
- Glasgow RE, McKay HG, Piette JD, Reynolds KD. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001 Aug;44(2):119-27. doi: 10.1016/s0738-3991(00)00186-5.
- Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Arch Fam Med. 2000 Jun;9(6):506-15. doi: 10.1001/archfami.9.6.506.
- Lajous M, Mozaffarian D, Mozaffarian R, Schrag D, Adami HO. Lifestyle prescriptions for cancer survivors and their communities. J Intern Med. 2011 Jan;269(1):88-93. doi: 10.1111/j.1365-2796.2010.02273.x. Epub 2010 Sep 24. Erratum In: J Intern Med. 2011 Mar;269(3):363.
- Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004 Jul;148(1):16-26. doi: 10.1016/j.ahj.2003.10.022.
- Clauser SB, Wagner EH, Aiello Bowles EJ, Tuzzio L, Greene SM. Improving modern cancer care through information technology. Am J Prev Med. 2011 May;40(5 Suppl 2):S198-207. doi: 10.1016/j.amepre.2011.01.014.
- Jones LW, Courneya KS, Fairey AS, Mackey JR. Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med. 2004 Oct;28(2):105-13. doi: 10.1207/s15324796abm2802_5.
- Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007 Oct 9;50(15):1435-41. doi: 10.1016/j.jacc.2007.06.037. Epub 2007 Sep 24.
- Singla A, Kumar G, Bardia A. Personalizing cardiovascular disease prevention among breast cancer survivors. Curr Opin Cardiol. 2012 Sep;27(5):515-24. doi: 10.1097/HCO.0b013e3283570040.
- Emery JD, Shaw K, Williams B, Mazza D, Fallon-Ferguson J, Varlow M, Trevena LJ. The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol. 2014 Jan;11(1):38-48. doi: 10.1038/nrclinonc.2013.212. Epub 2013 Nov 19.
- Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes Obes Metab. 2011 Dec;13(12):1063-72. doi: 10.1111/j.1463-1326.2011.01464.x.
- Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Milani RV, Sagalowsky AI, Smith MR, Zakai N; American Heart Association Council on Clinical Cardiology and Council on Epidemiology and Prevention, the American Cancer Society, and the American Urological Association. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation. 2010 Feb 16;121(6):833-40. doi: 10.1161/CIRCULATIONAHA.109.192695. Epub 2010 Feb 1. No abstract available.
- Azrad M, Demark-Wahnefried W. The association between adiposity and breast cancer recurrence and survival: A review of the recent literature. Curr Nutr Rep. 2014 Mar;3(1):9-15. doi: 10.1007/s13668-013-0068-9.
- Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W. Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev. 2014 Sep;15(9):749-68. doi: 10.1111/obr.12190. Epub 2014 May 29.
- Winters-Stone KM, Beer TM. Review of exercise studies in prostate cancer survivors receiving androgen deprivation therapy calls for an aggressive research agenda to generate high-quality evidence and guidance for exercise as standard of care. J Clin Oncol. 2014 Aug 10;32(23):2518-9. doi: 10.1200/JCO.2014.55.8189. Epub 2014 Jul 7. No abstract available.
- Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003 Apr 15;21(8):1447-51. doi: 10.1200/JCO.2003.03.060.
- Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000165. doi: 10.1002/14651858.CD000165.pub3.
- Chang VW, Lauderdale DS. Fundamental cause theory, technological innovation, and health disparities: the case of cholesterol in the era of statins. J Health Soc Behav. 2009 Sep;50(3):245-60. doi: 10.1177/002214650905000301.
- Van Blarigan EL, Meyerhardt JA. Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol. 2015 Jun 1;33(16):1825-34. doi: 10.1200/JCO.2014.59.7799. Epub 2015 Apr 27.
- Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010 Feb 2;121(4):586-613. doi: 10.1161/CIRCULATIONAHA.109.192703. Epub 2010 Jan 20.
- Murray DM, Pals SL, Blitstein JL, Alfano CM, Lehman J. Design and analysis of group-randomized trials in cancer: a review of current practices. J Natl Cancer Inst. 2008 Apr 2;100(7):483-91. doi: 10.1093/jnci/djn066. Epub 2008 Mar 25.
- Murray DM, Varnell SP, Blitstein JL. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health. 2004 Mar;94(3):423-32. doi: 10.2105/ajph.94.3.423.
- Byers T, Patnaik JL. Missed opportunities for chronic disease prevention after breast cancer. Womens Health (Lond). 2011 Nov;7(6):619-21. doi: 10.2217/whe.11.66. No abstract available.
- Hurt RD, Ebbert JO, Hays JT, McFadden DD. Preventing lung cancer by treating tobacco dependence. Clin Chest Med. 2011 Dec;32(4):645-57. doi: 10.1016/j.ccm.2011.08.004.
- Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999 Sep;89(9):1322-7. doi: 10.2105/ajph.89.9.1322.
- Lenihan DJ, Cardinale DM. Late cardiac effects of cancer treatment. J Clin Oncol. 2012 Oct 20;30(30):3657-64. doi: 10.1200/JCO.2012.45.2938. Epub 2012 Sep 24. Erratum In: J Clin Oncol. 2012 Dec 20;30(36):4590.
- Ligibel J. Lifestyle factors in cancer survivorship. J Clin Oncol. 2012 Oct 20;30(30):3697-704. doi: 10.1200/JCO.2012.42.0638. Epub 2012 Sep 24.
- Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population; Board on Health Care Services; Institute of Medicine; Levit L, Balogh E, Nass S, Ganz PA, editors. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington (DC): National Academies Press (US); 2013 Dec 27. Available from http://www.ncbi.nlm.nih.gov/books/NBK202148/
- 2020. "Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03935282.
Frequently Asked Questions
Are there any available slots left in this research project?
"Clinicaltrials.gov affirms that this particular medical trial is no longer recruiting patients at the present time, having been initially listed on October 1st 2020 and most recently updated November 3rd 2022. However, 7027 other trials are actively searching for participants right now." - Anonymous Online Contributor
Unverified Answer
How widespread is this medical trial across the state?
"11 prospective clinical trial centres are currently signing up patients. These sites span cities such as Saint Louis, Scranton and Appleton among 11 other locales. It is advised that you select the closest clinic to your location in order to reduce travelling requirements should you choose to join this study." - Anonymous Online Contributor
Unverified Answer